BIG
BIO icon

Brooklyn Investment Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Brooklyn Investment Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-95
Closed -$22.9K – 904
2025
Q2 		$22.9K Buy
95
+51
+116% +$12.1K ﹤0.01% 1763
2025
Q1 		$10.7K Sell
44
-4
-8% -$1.2K ﹤0.01% 1480
2024
Q4 		$15.8K Buy
48
+23
+92% +$7.81K ﹤0.01% 821
2024
Q3 		$8.37K Buy
+25
New +$7.94K ﹤0.01% 803

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Brooklyn Investment Group's BIO Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2025, closing a stake of 95 shares — an estimated $22.9K sold.

Brooklyn Investment Group first reported a position in BIO in Q3 2024 and held it in 4 quarters. The position peaked at $22.9K in Q2 2025. 397 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Bio-Rad Laboratories Class A position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 95 Bio-Rad Laboratories Class A shares in Q3 2025, an estimated $22.9K.
  • Brooklyn Investment Group first reported a position in Bio-Rad Laboratories Class A in Q3 2024 and held it in 4 quarters.
  • Brooklyn Investment Group's Bio-Rad Laboratories Class A position peaked at $22.9K in Q2 2025.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.